EUCR
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
EUCR
Delisted
EUCR was delisted on the 26th of April, 2023.
31 hedge funds and large institutions have $47.8M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.94M | |
| 2 | +$1.97M | |
| 3 | +$1.65M | |
| 4 |
D.E. Shaw & Co
New York
|
+$1.19M |
| 5 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
+$985K |
Top Sellers
| 1 | -$3.7M | |
| 2 | -$985K | |
| 3 | -$652K | |
| 4 |
CC
Centiva Capital
New York
|
-$3.94K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.51K |